TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
GOSS

Gossamer Bio Inc

Healthcare · Biotechnology

10.90$ +0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Gossamer Bio Inc (GOSS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 48 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GOSS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115 48
0.0 0.0 0.3 3.1 4.3 5.2 4.4 4.4 4.2 1.0
0.0 0.0 -0.3 -3.1 -4.3 -5.2 -4.4 -4.4 115 47
0.0 0.9 55 143 158 170 171 135 138 174
0.1 0.3 44 39 50 46 48 38 36 38
0.1 1.2 99 183 206 216 219 184 175 211
-0.1 -6.7 -149 -186 -211 -216 -219 -184 -60 -163
0.0 0.1 0.0 0.0 13 19 14 14 12 11
-0.1 -6.8 -147 -180 -243 -234 -229 -180 -56 -170
-0.1 -5.4 2.0 0.5 8.2 15 11 10 0.9 -0.1
-0.1 -6.8 -147 -181 -243 -234 -229 -180 -57 -170
-0.1 -6.7 -149 -179 -226 -209 -211 -162 -40 -158

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?